CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5655-5664

  Ishii, Makoto ^a   Asano, Koichiro ^a   Namkoong, Ho ^a   Tasaka, Sadatomo ^a   Mizoguchi, Kosuke ^a   Asami, Takahiro ^a   Kamata, Hirofumi ^a   Kimizuka, Yoshifumi ^a   Fujiwara, Hiroshi ^a   Funatsu, Yohei ^a   Kagawa, Shizuko ^a   Miyata, Jun ^a   Ishii, Ken ^a   Nakamura, Masataka ^b   Hirai, Hiroyuki ^c   Nagata, Kinya ^c   Kunkel, Steven L ^d   Hasegawa, Naoki ^a   Betsuyaku, Tomoko ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c BioMedical Laboratories   (Japan)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT RECEPTOR HOMOLOGOUS MOLECULE EXPRESSED IN TH2 CELLS; CHEMOKINE RECEPTOR CXCR2; HISTONE H3; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; BIOACCUMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIGENETICS; FEMALE; HISTONE ACETYLATION; INFECTION RESISTANCE; LETHALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEPSIS; SURVIVAL RATE; WILD TYPE;

ANIMALS; BACTERIAL LOAD; CECUM; CELL MOVEMENT; CELL SURVIVAL; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; FEMALE; INFLAMMATION MEDIATORS; LIGATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHILS; PUNCTURES; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SEPSIS;

EID: 84862059476     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102330     Document Type: Article

References (51)

1. Pinheiro da Silva, F., and F. G. Soriano. 2009. Neutrophils recruitment during sepsis: critical points and crossroads. Front. Biosci. 14: 4464-4476.
2. Alves-Filho, J. C., A. de Freitas, F. Spiller, F. O. Souto, and F. Q. Cunha. 2008. The role of neutrophils in severe sepsis. Shock 30(Suppl. 1): 3-9.
3. Johnston, R. A., J. P. Mizgerd, and S. A. Shore. 2005. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L61-L67. (Pubitemid 40023887)
4. Granström, E. 1984. The arachidonic acid cascade: the prostaglandins, thromboxanes and leukotrienes. Inflammation 8(Suppl.): S15-S25. (Pubitemid 14017385)
5. 2 and reproduction. Am. J. Reprod. Immunol. 47: 295-302.
6. 2 receptors DP1 and CRTH2 in promoting allergic responses. Br. J. Pharmacol. 153(Suppl. 1): S191-S199.
7. Mrabet-Dahbi, S., M. Metz, A. Dudeck, T. Zuberbier, and M. Maurer. 2009. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp. Dermatol. 18: 437-444.
8. 2. J. Pharmacol. Exp. Ther. 326: 493-501.
9. Nagata, K., K. Tanaka, K. Ogawa, K. Kemmotsu, T. Imai, O. Yoshie, H. Abe, K. Tada, M. Nakamura, K. Sugamura, and S. Takano. 1999. Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162: 1278-1286. (Pubitemid 29306996)
10. Cosmi, L., F. Annunziato, K. Nagata, S. Romagnani, K. Nagata, and S. Romagnani; Galli MIG; Maggi RME. 2000. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur. J. Immunol. 30: 2972-2979.
11. Nagata, K., H. Hirai, K. Tanaka, K. Ogawa, T. Aso, K. Sugamura, M. Nakamura, and S. Takano. 1999. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor (s). FEBS Lett. 459: 195-199. (Pubitemid 29475029)
12. Hirai, H., K. Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, Y. Takamori, M. Ichimasa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata. 2001. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosi- nophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193: 255-261. (Pubitemid 32524457)
13. Kim, N., and A. D. Luster. 2007. Regulation of immune cells by eicosanoid receptors. ScientificWorldJournal 7: 1307-1328. (Pubitemid 47435438)
14. Takeshita, K., T. Yamasaki, K. Nagao, H. Sugimoto, M. Shichijo, F. Gantner, and K. B. Bacon. 2004. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int. Immunol. 16: 947-959. (Pubitemid 38960873)
15. Shiraishi, Y., K. Asano, K. Niimi, K. Fukunaga, M. Wakaki, J. Kagyo, T. Takihara, S. Ueda, T. Nakajima, T. Oguma, et al. 2008. Cyclooxygenase-2/ prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. J. Immunol. 180: 541-549.
16. Monneret, G., H. Li, J. Vasilescu, J. Rokach, and W. S. Powell. 2002. 15- Deoxy-d 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J. Immunol. 168: 3563-3569. (Pubitemid 34250426)
17. Cook, J. A. 2005. Eicosanoids. Crit. Care Med. 33(12, Suppl.)S488-S491. (Pubitemid 41785997)
18. 2 regulates critical inflammatory mediators of multiple organ failure. J. Surg. Res. 56: 199-205.
19. 2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15: 42-49.
20. Zardi, E. M., D. M. Zardi, A. Dobrina, and A. Afeltra. 2007. Prostacyclin in sepsis: a systematic review. Prostaglandins Other Lipid Mediat. 83: 1-24. (Pubitemid 46149410)
21. Suchner, U., D. P. Katz, P. Fürst, K. Beck, T. W. Felbinger, M. Thiel, U. Senftleben, A. E. Goetz, and K. Peter. 2002. Impact of sepsis, lung injury, and the role of lipid infusion on circulating prostacyclin and thromboxane A2. Intensive Care Med. 28: 122-129. (Pubitemid 34293823)
22. 2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J. Immunol. 177: 2621-2629.
23. Hubbard, W. J., M. Choudhry, M. G. Schwacha, J. D. Kerby, L. W. Rue, III, K. I. Bland, and I. H. Chaudry. 2005. Cecal ligation and puncture. Shock 24(Suppl. 1): 52-57.
24. Ishii, M., C. M. Hogaboam, A. Joshi, T. Ito, D. J. Fong, and S. L. Kunkel. 2008. CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling. Eur. J. Immunol. 38: 2290-2302.
25. Lyons, A., A. Goebel, J. A. Mannick, and J. A. Lederer. 1999. Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. Arch. Surg. 134: 1317-1323, discussion 1324.
26. Nicoletti, F., R. Di Marco, P. Zaccone, G. Magro, M. Di Mauro, S. Grasso, and P. L. Meroni. 1999. Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease. Immunology 97: 367-370. (Pubitemid 29314630)
27. Alves-Filho, J. C., F. Sônego, F. O. Souto, A. Freitas, W. A. Verri, Jr., M. Auxiliadora-Martins, A. Basile-Filho, A. N. McKenzie, D. Xu, F. Q. Cunha, and F. Y. Liew. 2010. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 16: 708-712.
28. Cotter, M. J., K. E. Norman, P. G. Hellewell, and V. C. Ridger. 2001. A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am. J. Pathol. 159: 473-481. (Pubitemid 32751078)
29. Suzuki, Y., K. Asano, K. Niimi, J. Miyata, Y. Shiraishi, K. Fukunaga, T. Shiomi, T. Nakajima, T. Oguma, K. Sayama, and A. Ishizaka. 2008. TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells. Eur. J. Pharmacol. 600: 133-139.
30. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150. (Pubitemid 36056721)
31. Steinhauser, M. L., C. M. Hogaboam, N. W. Lukacs, R. M. Strieter, and S. L. Kunkel. 1999. Multiple roles for IL-12 in a model of acute septic peritonitis. J. Immunol. 162: 5437-5443. (Pubitemid 29307153)
32. Moreno, S. E., J. C. Alves-Filho, T. M. Alfaya, J. S. da Silva, S. H. Ferreira, and F. Y. Liew. 2006. IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J. Immunol. 177: 3218-3224. (Pubitemid 44277840)
33. van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155: 5397-5401. (Pubitemid 3015364)
34. Kasten, K. R., J. T. Muenzer, and C. C. Caldwell. 2010. Neutrophils are significant producers of IL-10 during sepsis. Biochem. Biophys. Res. Commun. 393: 28-31.
35. Reddy, R. C., and T. J. Standiford. 2010. Effects of sepsis on neutrophil chemotaxis. Curr. Opin. Hematol. 17: 18-24.
36. Reddy, R. C., V. R. Narala, V. G. Keshamouni, J. E. Milam, M. W. Newstead, and T. J. Standiford. 2008. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-gamma. Blood 112: 4250-4258.
37. Olson, T. S., and K. Ley. 2002. Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R7-R28. (Pubitemid 34863907)
38. Cummings, C. J., T. R. Martin, C. W. Frevert, J. M. Quan, V. A. Wong, S. M. Mongovin, T. R. Hagen, K. P. Steinberg, and R. B. Goodman. 1999. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 162: 2341-2346. (Pubitemid 29288860)
39. Baron, E. J., and R. A. Proctor. 1982. Elicitation of peritoneal polymorphonuclear neutrophils from mice. J. Immunol. Methods 49: 305-313. (Pubitemid 12191746)
40. Benjamim, C. F., C. M. Hogaboam, and S. L. Kunkel. 2004. The chronic consequences of severe sepsis. J. Leukoc. Biol. 75: 408-412. (Pubitemid 38316370)
41. 2), a peroxisome proliferator activated receptor γ ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Shock 24: 59-65.
42. Manthous, C. A., J. B. Hall, and R. W. Samsel. 1993. Endotoxin in human disease. Part 1: Biochemistry, assay, and possible role in diverse disease states. Chest 104: 1572-1581. (Pubitemid 23327883)
43. Ye, X., and S. F. Liu. 2002. Lipopolysaccharide down-regulates Sp1 binding activity by promoting Sp1 protein dephosphorylation and degradation. J. Biol. Chem. 277: 31863-31870. (Pubitemid 34968994)
44. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gërard, A. Delvaux, D. De Groote, D. Abramowicz, T. Velu, and M. Goldman. 1994. Interleukin-10 controls interferon-g and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24: 1167-1171.
45. Sewnath, M. E., D. P. Olszyna, R. Birjmohun, F. J. ten Kate, D. J. Gouma, and T. van Der Poll. 2001. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J. Immunol. 166: 6323-6331. (Pubitemid 32440765)
46. Carson, W. F., K. A. Cavassani, Y. Dou, and S. L. Kunkel. 2011. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 6: 273-283.
47. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293: 1074-1080. (Pubitemid 32758077)
48. Chen, C., M. Zhao, N. Yin, B. He, B. Wang, Y. Yuan, F. Yu, J. Hu, B. Yin, and Q. Lu. 2011. Abnormal histone acetylation and methylation levels in esophageal squamous cell carcinomas. Cancer Invest. 29: 548-556.
49. Zhao, M., G. Liang, X. Wu, S. Wang, P. Zhang, Y. Su, H. Yin, Y. Tan, J. Zhang, and Q. Lu. 2012. Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata. Br. J. Dermatol. 166: 266-273.
50. Vroon, A., C. J. Heijnen, and A. Kavelaars. 2006. GRKs and arrestins: regulators of migration and inflammation. J. Leukoc. Biol. 80: 1214-1221. (Pubitemid 44904958)
51. Guo, Z., M. Zhang, H. Tang, and X. Cao. 2005. Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood 106: 2033-2041. (Pubitemid 41291717)